We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALT market cap is 477.22M. The company's latest EPS is USD -1.2475 and P/E is -5.41.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21k | 6k | 362k | 37k | 5k |
| Operating Income | -21.76M | -18.01M | -22.54M | -33.62M | -26.79M |
| Net Income | -20.07M | -16.06M | -20.67M | -31.64M | -24.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.8M | 8.19M | 4.41M | -68k | 426k |
| Operating Income | -20.47M | -54.8M | -85.92M | -87.74M | -95.93M |
| Net Income | -20.97M | -49.04M | -97.09M | -84.71M | -88.45M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 187.08M | 183.32M | 166.57M | 210.64M | 188.36M |
| Total Liabilities | 19.35M | 15.6M | 16.18M | 16.54M | 15.42M |
| Total Equity | 167.73M | 167.71M | 150.4M | 194.1M | 172.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.06M | 245.12M | 218.87M | 206.93M | 210.64M |
| Total Liabilities | 8.54M | 19.24M | 19.73M | 21.64M | 16.54M |
| Total Equity | 45.52M | 225.88M | 199.14M | 185.29M | 194.1M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.41M | -38.79M | -59.28M | -75.81M | -16.36M |
| Investing | 13.3M | 17.29M | 21.69M | 13.73M | -39.52M |
| Financing | -302k | 12.76M | 13.35M | 86.11M | -261k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.6M | -34.44M | -78.24M | -62.59M | -75.81M |
| Investing | -28.29M | -72.1M | 87.52M | -73.4M | 13.73M |
| Financing | 12.53M | 213.49M | 65.1M | 56.78M | 86.11M |
| Market Cap | 477.22M |
| Price to Earnings Ratio | -5.41 |
| Price to Sales Ratio | 1.13k |
| Price to Cash Ratio | 3.54 |
| Price to Book Ratio | 2.47 |
| Dividend Yield | - |
| Shares Outstanding | 70.9M |
| Average Volume (1 week) | 2.23M |
| Average Volume (1 Month) | 3.11M |
| 52 Week Change | 123.61% |
| 52 Week High | 14.84 |
| 52 Week Low | 2.09 |
| Spread (Intraday) | 1.41 (18.41%) |
| Company Name | Altimmune Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.altimmune.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
